Are you a US healthcare provider?

This web portal is intended as an educational resource for healthcare providers practicing in the United States. It may include information about products or uses that have not been approved by the US Food and Drug Administration.

If you are not a healthcare provider, please discuss any questions you have regarding your health or medicines with your doctor, pharmacist, or nurse.

Overton ET, et al. Long-acting cabotegravir + rilpivirine every 2 months: ATLAS-2M week 152 results. Presented at the 29th Conference on Retroviruses and Opportunistic Infections (CROI), February 12-16, 2022, Virtual Event. Poster.

Zoom in or click an area to see more details.

×
X
×

Connect with our Medical Experts

Find my ViiV MSL

Easily find the ViiV Medical Science Liaison (MSL) in your area.

Request a Scientific Discussion

Submit a request for additional information from a ViiV Medical Expert.

Talk to a Medical Expert

Connect now with a live ViiV Medical Expert.

Contact Us

Chat Live

Get immediate assistance from a ViiV Healthcare Professional.

Call 1-888-226-8434

Weekdays from 8 AM to 6 PM ET
(5 AM – 3 PM PT)

Report an Adverse Event

To report SUSPECTED ADVERSE REACTIONS, contact ViiV Healthcare at 1-877-844-8872 or FDA at 1-800-332-1088 or www.fda.gov/medwatch